ClinicalTrials.gg
CompletedNCT04239729Updated Apr 27, 2021

Web-based Acceptance and Commitment Therapy for Hoarding Disorder

An interventional study of ACT Website and Coaching in Hoarding Disorder, sponsored by Utah State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-27.

Sponsored by Utah State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will help to determine if acceptance and commitment therapy delivered as a web-based intervention is a useful treatment for hoarding disorder and evaluate whether or not web-based treatment for hoarding is credible and acceptable. It may also help identify novel processes of change in hoarding treatment such as psychological inflexibility, mindfulness, and self-stigma.

Read the detailed description

The efficacy of an ACT self-help website for hoarding will be assessed through a randomized, waitlist-controlled trial. Participants will be recruited from within the United States through a variety of channels. Given the need to recruit a targeted sample with clinical levels of hoarding symptoms, online advertisements through Facebook and Google AdWords will be the primary recruitment method. Participants will complete an initial brief screening, provide consent, and then complete a baseline survey. Each of these steps will be completed online and participants will be automatically guided from each step to the next. That is, those who screen as eligible will be automatically directed to an online consent form, and those who provide consent will be automatically directed to begin the initial online baseline survey. They will be randomly assigned automatically upon completing the baseline survey to either use the ACT self-help website and receive supportive coaching for the next 8 weeks, or wait for the next 8 weeks. After 8 weeks, participants will be asked to complete a posttreatment survey. They will be asked to complete a final, follow-up survey after an additional 4 weeks after the posttreatment survey. After the follow-up survey is completed, waitlisted participants will be provided with access to the website. The website will implement a self-help version of ACT. Participants will be asked to complete 16 brief self-help website sessions, each taking around 15-20 minutes to finish, twice a week for eight weeks. Participants assigned to the website condition will also receive coaching.The purpose of coaching will be to help participants engage with the website and adhere to the intervention. Coaching will consist of an initial phone call of 10-15 minutes followed by weekly email contact during the 8-week treatment period. Coaches will be graduate students trained in clinical psychology.

02

Conditions studied

  • Hoarding Disorder

Browse trials for

03

In context

Hoarding Disorder

32 studies on the registry are indexed under Hoarding Disorder; 5 are open to participants now.

This study's enrollment of 80 is above the median of 37 across 28 interventional studies indexed under Hoarding Disorder.

Browse Hoarding Disorder studies →

Lead sponsor

Utah State University is the lead sponsor of 39 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years old or older
  2. Living in the USA
  3. Seeking help for clutter and/or hoarding
  4. Interested in testing a self-help website
  5. Scoring at or above the clinical cutoff of 41 on the Saving Inventory-Revised

Exclusion criteria

Exclusion Criteria:

  1. 17 years or younger
  2. Living outside the USA
  3. Not seeking help for clutter and/or hoarding
  4. Not interested in testing a self-help website
  5. Scoring below 41 on the Saving Inventory-Revised
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    ACT Website and Coaching Condition

    Participants will be asked to complete 16 brief self-help website sessions, each taking around 15-20 minutes to finish, twice a week for eight weeks. Website exercises and examples primarily focus on hoarding, although some examples also discuss related mental health concerns such as anxiety, low mood, health behaviors, etc. The sessions use multimedia and are interactive. Participants assigned to the website condition will also receive coaching. The purpose of coaching will be to help participants engage with the website and adhere to the intervention. Coaching will consist of an initial phone call of 10-15 minutes followed by weekly email contact during the 8-week treatment period. Coaches will be graduate students trained in clinical psychology.

    Behavioral: ACT Website and Coaching

  • No intervention
    Waitlist Condition

    Participants assigned to the waitlist will be asked to wait 12 weeks without intervention (access to the website or coaching). They will receive access to the website after 12 weeks, but supportive coaching will not be provided to waitlist participants.

Interventions

  • BehavioralACT Website and Coaching

    The ACT website includes sixteen sessions and is designed to teach a series of skills from ACT applied to hoarding. The intervention also includes brief supportive coaching (an initial phone call and weekly support over email).

06

What researchers measure

Primary outcomes

  1. Saving Inventory-Revised (SI-R; Frost et al., 2004)

    A self-report measure of hoarding symptoms

    Time frame: Posttreatment (8 weeks after baseline)

Secondary outcomes

  1. Sheehan Disability Scale (Sheehan, Harnett-Sheehan, & Raj, 1996)

    A self-report measure of functional impairment due to symptoms. Higher scores indicate greater impairment. Scores range from 0 to 30.

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  2. Clinical Global Impression - Improvement (CGI-I; Guy, 1976).

    A self-report measure of overall improvement in symptoms

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  3. General Health Questionnaire-12 (GHQ-12; Goldberg, 1978)

    A self-report measure of overall psychological distress

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  4. Stigma of hoarding items (Chasson et al., 2018)

    Seven self-report items assessing stigma towards individuals with hoarding disorder. These items are not a standardized scale but have been used in previous research (Chasson et al., 2018). Three items assess perceived difference (Example: How like or unlike do you think is a person with obsessive-compulsive disorder compared to everyone else in the general population?), three items assess disdain (Example: How good or bad do you think is a person with hoarding disorder compared to everyone else in the general population?) and one item assesses blame: How responsible do you think a person with serious mental illness is for his or her condition?

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  5. Acceptance and Action Questionnaire for Hoarding (AAQH; Krafft et al., in press)

    A self-report measure of hoarding-related psychological inflexibility

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  6. Five-Facet Mindfulness Questionnaire - Acting with Awareness (FFMQ-AA; Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006)

    A self-report measure of the acting with awareness facet of mindfulness

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  7. Valuing Questionnaire-Progress (VQ-Progress; Smout, Davies, Burns, & Christie, 2014)

    A self-report measure of progress toward personal values

    Time frame: Posttreatment (8 weeks after baseline) and follow-up (12 weeks after baseline)

  8. Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000).

    A self-report measure of the perceived credibility of and expectations toward a treatment. Only administered to treatment condition

    Time frame: After using first website session (approximately 0-1 weeks after baseline)

  9. System Usability Scale (Tullis & Albert, 2008)

    A self-report measure of usability of a technological system. Only administered to treatment condition. High scores indicated greater usability, and scores range from 0 to 100.

    Time frame: Posttreatment (8 weeks after baseline)

  10. Treatment Evaluation Inventory-Short Form (TEI-SF; Kelley, Heffer, Gresham, & Elliott, 1989).

    A self-report measure of treatment acceptability. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  11. Novel satisfaction item 1

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "Overall, I was satisfied with the quality of the program." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  12. Novel satisfaction item 2

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "The program was helpful to me." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  13. Novel satisfaction item 3

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "The program was easy to use." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  14. Novel satisfaction item 4

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "I felt the program was made for someone like me." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  15. Novel satisfaction item 5

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "I would recommend the program to other people with a clutter and/or hoarding problem." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  16. Novel satisfaction item 6

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "The psychological skills taught (ex. mindfulness, opening up) were helpful to me." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  17. Novel satisfaction item 7

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "The practice exercises (ex. discarding, goal setting) were helpful to me." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  18. Novel satisfaction item 8

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "This treatment fit well with my goals." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  19. Novel satisfaction item 9

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "Overall, I was satisfied with the coaching that I received." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  20. Novel satisfaction item 10

    Participants will be asked to rate agreement from 1 (Strongly disagree) to 6 (Strongly agree) with the statement "The website would have been just as useful without a coach." This is a novel satisfaction item specific to this study. Only administered to treatment condition

    Time frame: Posttreatment (8 weeks after baseline)

  21. Novel satisfaction item 11

    Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to treatment condition. The question is, "What did you like best about the Making Space program?"

    Time frame: Posttreatment (8 weeks after baseline)

  22. Novel satisfaction item 12

    Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to treatment condition. The question is, "What was the most important thing you learned from the Making Space program?"

    Time frame: Posttreatment (8 weeks after baseline)

  23. Novel satisfaction item 13

    Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to treatment condition. The question is, "What did you like least about the Making Space Program? Why did you like this the least?"

    Time frame: Posttreatment (8 weeks after baseline)

  24. Novel satisfaction item 14

    Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to treatment condition. The question is, "Do you have any other comments or suggestions regarding our Making Space program?"

    Time frame: Posttreatment (8 weeks after baseline)

07

Study locations

1 site
  • Utah State University
    Logan, Utah 84322, United States
08

References and documents

Publications

  • Frost RO, Steketee G, Grisham J. Measurement of compulsive hoarding: saving inventory-revised. Behav Res Ther. 2004 Oct;42(10):1163-82. doi: 10.1016/j.brat.2003.07.006. PubMed 15350856 ↗
  • Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95. doi: 10.1097/00004850-199606003-00015. PubMed 8923116 ↗
  • Guy, W. (1976). Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ. No. ADM 76-338). Rockville, MD: National Institute of Mental Health.
  • Goldberg, D. (1978). Manual of the GHQ. Windsor: NFER.
  • Chasson, G. S., Guy, A. A., Bates, S., & Corrigan, P. W. (2018). They aren't like me, they are bad, and they are to blame: A theoretically-informed study of stigma of hoarding disorder and obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders, 16, 56-65. http://doi.org/10.1016/j.jocrd.2017.12.006
  • Krafft, J., Ong, C. W., Twohig, M. P., & Levin, M. E. (In press). Assessing psychological inflexibility in hoarding: The Acceptance and Action Questionnaire for Hoarding (AAQH). Journal of Contextual Behavioral Science.http://doi.org/10.1016/j.jcbs.2018.08.003
  • Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006 Mar;13(1):27-45. doi: 10.1177/1073191105283504. PubMed 16443717 ↗
  • Smout, M., Davies, M., Burns, N., & Christie, A. (2014). Development of the Valuing Questionnaire (VQ). Journal of Contextual Behavioral Science, 3, 164-172. http://doi.org/10.1016/j.jcbs.2014.06.001
  • Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86. doi: 10.1016/s0005-7916(00)00012-4. PubMed 11132119 ↗
  • Tullis, T., & Albert, W. (2008). Measuring the user experience. San Francisco, CA: Morgan Kaufmann.
  • Kelley, M. L., Heffer, R. W., Gresham, F. M., & Elliott, S. N. (1989). Development of a modified treatment evaluation inventory. Journal of Psychopathology and Behavioral Assessment, 11, 235-247.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2020 to primary completion in Nov 2020, 9 months.

Of 20 interventional studies with no phase under Hoarding Disorder, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 48. This study's 9 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2020
First posted
Jan 27, 2020
StartActual
Feb 17, 2020
Primary completionActual
Nov 27, 2020
CompletionActual
Nov 27, 2020
Last update
Apr 27, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04239729
Lead sponsor
Utah State University
Responsible party
Sponsor
First posted
Jan 27, 2020
Start date
Feb 17, 2020
Primary completion
Nov 27, 2020
Completion
Nov 27, 2020
Last update
Apr 27, 2021

Study contacts

Michael E Levin, PhD
principal investigator · Utah State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion